Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis

NCT04762953 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Peritoneal Carcinomatosis
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Paclitaxel
DRUG: Paclitaxel
DRUG: Leucovorin
DRUG: Fluorouracil

Sponsor

University of California, Irvine